SynthesisJournal of robotic surgery2026
Robotic-assisted surgery for parastomal hernia repair: a systematic review and meta-analysis.
Synthesis in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To systematically review the current evidence on robotic-assisted parastomal hernia repair (RPHR), evaluating its technical feasibility, safety, and short-term outcomes, with a specific focus on recurrence rates, postoperative complications, and the influence of prior repair history. A systematic review and meta-analysis was conducted following PRISMA guidelines, searching PubMed, Embase, Scopus, Web of Science, and the Cochrane Library. Sixteen studies involving 273 patients were included for qualitative synthesis. Four of these studies, reporting on outcomes based on prior repair history, were eligible for meta-analysis. Key variables included patient demographics, operative metrics, recurrence, and complications. The included studies suggest RPHR is technically feasible, with a low conversion-to-open rate of 0.7%. The pooled data showed a recurrence rate of 5.4% at a short-term mean follow-up of 15 months. This finding must be interpreted with caution, as the brief follow-up period severely limits direct comparisons with open surgery studies, which often report outcomes over longer periods (e.g., 24 months or more). The postoperative complication rate was substantial at 43.0%. This is likely multifactorial, attributable not only to patient-related factors (e.g., mean BMI 28.2 kg/m2) but also to procedural factors, including long mean operative times (230 minutes), institutional learning curves, and the inherent technical challenges of the RPHR procedure. The meta-analysis on the impact of prior repair history was severely underpowered. For recurrence, the analysis of a small cohort (n=25) yielded an inconclusive result with an extremely wide confidence interval (RR=3.02; 95% CI: 0.40–22.76), precluding any definitive conclusions about risk. Therefore, the finding that prior repair history did not increase risk cannot be substantiated. RPHR appears to be a technically feasible approach for parastomal hernia. However, the current evidence, based largely on retrospective studies, is preliminary. The observed 5.4% recurrence rate at 15 months is noted but must be interpreted with significant caution due to the short follow-up. The high 43.0% complication rate warrants further investigation and appears to reflect a combination of patient complexity, procedural challenges, and learning curve effects. The influence of prior repair history on outcomes remains inconclusive due to severely underpowered analyses. Definitive conclusions on the efficacy and safety of RPHR await larger, methodologically rigorous prospective studies with long-term follow-up to provide higher-certainty evidence.
Indexed as
Identifiers
41553648What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.